Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crizotinib in Children With Relapsed/Refractory Solid Tumors and ALCL
NCT00939770Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2009
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of crizotinib in solid tumor, anaplastic large cell lymphoma (ALCL), neuroblastoma, sponsored by Children's Oncology Group. Started Sep 2009; status: completed.
02
Drugs
crizotinib
03
Conditions
solid tumoranaplastic large cell lymphoma (ALCL)neuroblastoma
Beyond the preview
Go deeper on NCT00939770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939770.